Drugs / compound pholcodine oral solution
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05501288 | May → Jun 2022 | COVID-19 | Shanghai Children's Medical Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | compound pholcodine oral solution | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05501288 ↗ |
| Route | Oral | “Patients were given compound pholcodine oral solution” NCT05501288 ↗ |